You are here

Publications

] Year

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

I

Obinata H, Gutkind S, Stitham J, Okuno T, Yokomizo T, Hwa J, Hla T. 2014. Individual variation of human S1P1 coding sequence leads to heterogeneity in receptor function and drug interactions. J Lipid Res. 55(12):2665-75.

Wong AK, Krishnan A, Yao V, Tadych A, Troyanskaya OG. 2015. IMP 2.0: a multi-species functional genomics portal for integration, visualization and prediction of protein functions and networks. Nucleic Acids Res. 43(W1):W128-33.

H

Xiang Y, Cheng J, Wang D, Hu X, Xie Y, Stitham J, Atteya G, Du J, Tang WHo, Lee SHee et al.. 2015. Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor. Blood. 125(22):3377-87.

Gleim S, Stitham J, Tang WHo, Li H, Douville K, Chelikani P, Rade JJ, Martin KA, Hwa J. 2013. Human thromboxane A2 receptor genetic variants: in silico, in vitro and "in platelet" analysis. PLoS One. 8(6):e67314.

Fitzgerald DJ, FitzGerald GA. 2013. Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism. Circ Res. 112(1):174-94.

G

Prilutsky D, Kho AT, Palmer NP, Bhakar AL, Smedemark-Margulies N, Kong SWon, Margulies DM, Bear MF, Kohane IS. 2015. Gene expression analysis in Fmr1KO mice identifies an immunological signature in brain tissue and mGluR5-related signaling in primary neuronal cultures.. Mol Autism. 6:66.

F

Keramati AR, Fathzadeh M, Go G-W, Singh R, Choi M, Faramarzi S, Mane S, Kasaei M, Sarajzadeh-Fard K, Hwa J et al.. 2014. A form of the metabolic syndrome associated with mutations in DYRK1B. N Engl J Med. 370(20):1909-19.

Goya J, Wong AK, Yao V, Krishnan A, Homilius M, Troyanskaya OG. 2015. FNTM: a server for predicting functional networks of tissues in mouse. Nucleic Acids Res. 43(W1):W182-7.

E

Li X, Ballantyne LL, Che X, Mewburn JD, Kang JX, Barkley RM, Murphy RC, Yu Y, Funk CD. 2015. Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in mice. J Am Heart Assoc. 4(4)

Proia RL, Hla T. 2015. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest. 125(4):1379-87.

Chang S-H, Elemento O, Zhang J, Zhuang ZW, Simons M, Hla T. 2014. ELAVL1 regulates alternative splicing of eIF4E transporter to promote postnatal angiogenesis. Proc Natl Acad Sci U S A. 111(51):18309-14.

Lu Y-C, Chang S-H, Hafner M, Li X, Tuschl T, Elemento O, Hla T. 2014. ELAVL1 Modulates Transcriptome-wide miRNA Binding in Murine Macrophages. Cell Rep. 9(6):2330-43.

Moore JH, Hwa J. 2014. Editorial: pharmacogenetics and molecular medicine: "so close and yet so far". Curr Mol Med. 14(7):803-4.

D

Griffin JL, Wang X, Stanley E. 2015. Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics. Circ Cardiovasc Genet. 8(1):187-91.

Guo L, Worth AJ, Mesaros C, Snyder NW, Glickson JD, Blair IA. 2016. Diisopropylethylamine/hexafluoroisopropanol-mediated ion-pairing ultra-high-performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism. Rapid Commun Mass Spectrom. 30(16):1835-45.

Li X, Fries S, Li R, Lawson JA, Propert KJ, Diamond SL, Blair IA, FitzGerald GA, Grosser T. 2014. Differential impairment of aspirin-dependent platelet cyclooxygenase acetylation by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A. 111(47):16830-5.

Dong L, Zou H, Yuan C, Hong YH, Kuklev DV, Smith WL. 2016. Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis. J Biol Chem. 291(8):4069-78.

Toung JM, Lahens N, Hogenesch JB, Grant G. 2014. Detection theory in identification of RNA-DNA sequence differences using RNA-sequencing. PLoS One. 9(11):e112040.

C

Yuan C, Smith WL. 2015. A Cyclooxygenase-2-dependent Prostaglandin E2 Biosynthetic System in the Golgi Apparatus. J Biol Chem. 290(9):5606-20.

Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK et al.. 2014. Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor. Cancer Res. 74(23):7069-78.

Stitham J, Vanichakarn P, Ying L, Hwa J. 2014. Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs. Curr Mol Med. 14(7):909-31.

Vanichakarn P, Hwa J, Stitham J. 2014. Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies. Curr Mol Med. 14(7):849-79.

B

Mazaleuskaya LL, Lawson JA, Li X, Grant G, Mesaros C, Grosser T, Blair IA, Ricciotti E, FitzGerald GA. 2016. A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood. JCI Insight. 1(12)

Jiang Y, Djuric Z, Sen A, Ren J, Kuklev D, Waters I, Zhao L, Uhlson CL, Hong YH, Murphy RC et al.. 2014. Biomarkers for personalizing omega-3 fatty acid dosing. Cancer Prev Res (Phila). 7(10):1011-22.

Chatr-Aryamontri A, Breitkreutz B-J, Oughtred R, Boucher L, Heinicke S, Chen D, Stark C, Breitkreutz A, Kolas N, O'Donnell L et al.. 2015. The BioGRID interaction database: 2015 update. Nucleic Acids Res. 43(Database issue):D470-8.

Pages